Statement of Changes in Beneficial Ownership (4)
July 19 2019 - 5:47PM
Edgar (US Regulatory)
X0306
4
2019-07-17
0
0001346830
Cara Therapeutics, Inc.
CARA
0001597152
Menzaghi Frederique Ph.D.
C/O CARA THERAPEUTICS, INC.
4 STAMFORD PLAZA, 107 ELM ST, 9TH FLOOR
STAMFORD
CT
06902
0
1
0
0
Chief Scientific Off,SVP-R&D
Common Stock
2019-07-17
4
S
0
8996
27.50
D
119886
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.50 to $27.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
/s/Darren DeStefano, Attorney-in-Fact
2019-07-19
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Sep 2023 to Sep 2024